The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
- Posted on December 20, 2024
- By Bing News
- 3 Views
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate-to-severe obstructive sleep apnea (OSA) for adults with obesity.